CorMedix Inc [NASDAQ: CRMD] loss -22.51% or -2.92 points to close at $10.05 with a heavy trading volume of 4363597 shares.
The daily chart for CRMD points out that the company has recorded 82.07% gains over the past six months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If we look at the average trading volume of 1.00M shares, CRMD reached to a volume of 4363597 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about CorMedix Inc [CRMD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CRMD shares is $17.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CRMD stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Rodman & Renshaw have made an estimate for CorMedix Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 26, 2024. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Outperform. The new note on the price target was released on August 10, 2023, representing the official price target for CorMedix Inc stock. Previously, the target price had yet another raise to $31, while Needham analysts kept a Buy rating on CRMD stock.
The Average True Range (ATR) for CorMedix Inc is set at 0.83, with the Price to Sales ratio for CRMD stock in the period of the last 12 months amounting to 716.66. The Price to Book ratio for the last quarter was 12.03, with the Price to Cash per share for the same quarter was set at 0.79.
Trading performance analysis for CRMD stock
CorMedix Inc [CRMD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -18.62. With this latest performance, CRMD shares gained by 24.07% in over the last four-week period, additionally plugging by 82.07% over the last 6 months – not to mention a rise of 215.05% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CRMD stock in for the last two-week period is set at 48.18, with the RSI for the last a single of trading hit 39.84, and the three-weeks RSI is set at 53.43 for CorMedix Inc [CRMD]. The present Moving Average for the last 50 days of trading for this stock 8.34, while it was recorded at 12.42 for the last single week of trading, and 5.37 for the last 200 days.
CorMedix Inc [CRMD]: A deeper dive into fundamental analysis
CorMedix Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.43 and a Current Ratio set at 4.79.
CorMedix Inc [CRMD]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, CorMedix Inc posted -0.17/share EPS, while the average EPS was predicted by analysts to be reported at -0.21/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.04. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CRMD.
An analysis of Institutional ownership at CorMedix Inc [CRMD]
There are presently around $29.89%, or 30.20%% of CRMD stock, in the hands of institutional investors. The top three institutional holders of CRMD stocks are: BLACKROCK INC. with ownership of 3.55 million shares, which is approximately 6.1796%. VANGUARD GROUP INC, holding 2.9 million shares of the stock with an approximate value of $$12.57 million in CRMD stocks shares; and VANGUARD GROUP INC, currently with $$6.71 million in CRMD stock with ownership which is approximately 2.6964%.
